Found: 34
Select item for more details and to access through your institution.
Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in Germany.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Development and validation of a nomogram to predict recurrence and melanoma‐specific mortality in patients with negative sentinel lymph nodes.
- Published in:
- British Journal of Surgery, 2019, v. 106, n. 3, p. 217, doi. 10.1002/bjs.10995
- By:
- Publication type:
- Article
A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 13, doi. 10.1007/s00280-015-2761-4
- By:
- Publication type:
- Article
Phase I, dose-finding study of AZD8931, an inhibitor of EGFR (erbB1), HER2 (erbB2) and HER3 (erbB3) signaling, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 1, p. 145, doi. 10.1007/s10637-013-9963-6
- By:
- Publication type:
- Article
Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie.
- Published in:
- Oncology, 2013, v. 84, n. 5, p. 284, doi. 10.1159/000345453
- By:
- Publication type:
- Article
Prognostic Relevance of Circulating Tumor Cells in Metastatic Uveal Melanoma.
- Published in:
- Oncology, 2011, v. 80, n. 1/2, p. 57, doi. 10.1159/000328283
- By:
- Publication type:
- Article
Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Simultanes Plattenepithelkarzinom und follikuläres Lymphom der Tonsille.
- Published in:
- HNO, 2010, v. 58, n. 12, p. 1192, doi. 10.1007/s00106-010-2107-9
- By:
- Publication type:
- Article
Regression of choroidal melanoma after primary chemotherapy.
- Published in:
- Acta Ophthalmologica (1755375X), 2010, v. 88, p. 0, doi. 10.1111/j.1755-3768.2010.4264.x
- By:
- Publication type:
- Article
Expression of the stem cell marker nestin in peripheral blood of patients with melanoma.
- Published in:
- British Journal of Dermatology, 2010, v. 163, n. 1, p. 107, doi. 10.1111/j.1365-2133.2010.09779.x
- By:
- Publication type:
- Article
Treatment of melanoma.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases.
- Published in:
- Eye, 2008, v. 22, n. 8, p. 997, doi. 10.1038/sj.eye.6702779
- By:
- Publication type:
- Article
Relative quantification of TCR Vbeta-chain families by real time PCR for identification of clonal T-cell populations.
- Published in:
- 2008
- By:
- Publication type:
- journal article
A Multicentre Phase II Study of Docetaxel plus Cisplatin for the Treatment of Advanced Gastric Cancer.
- Published in:
- Chemotherapy (0009-3157), 2007, v. 53, n. 6, p. 454, doi. 10.1159/000110042
- By:
- Publication type:
- Article
Phase II study of CLAD (cyclophosphamide, liposomal doxorubicin and dexamethasone) in patients with advanced multiple myeloma and historical comparison to CAD (cyclophosphamide, doxorubicin and dexamethasone)
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Phase II study of CLAD (cyclophosphamide, liposomal doxorubicin and dexamethasone) in patients with advanced multiple myeloma and historical comparison to CAD (cyclophosphamide, doxorubicin and dexamethasone).
- Published in:
- Hematological Oncology, 2007, v. 25, n. 3, p. 132, doi. 10.1002/hon.821
- By:
- Publication type:
- Article
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 2007, v. 39, n. 7, p. 389, doi. 10.1038/sj.bmt.1705605
- By:
- Publication type:
- Article
Wilms' tumour gene 1 (WT1) in human neoplasia.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 8, p. 1318, doi. 10.1038/sj.leu.2403817
- By:
- Publication type:
- Article
Immunotherapy in non-renal carcinomas.
- Published in:
- Der Urologe A, 2004, v. 43, n. 3, p. 138, doi. 10.1007/s00120-004-0605-7
- By:
- Publication type:
- Article
Phase I/II trial of topotecan given as continuous infusion in combination with oxaliplatin in 5-FU-pretreated patients with colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 2, p. 178, doi. 10.1007/s00280-004-0796-z
- By:
- Publication type:
- Article
Addition of histamine to IL-2 treatment augments T1 cell-function in melanoma patients in vivo: results from a randomized clinical trial of IL-2 with or without histamine (MP 104).
- Published in:
- Cancer Cell International, 2004, v. 4, p. 1
- By:
- Publication type:
- Article
Vaccination with WT1 induces high frequency memory and effector T cells in peripheral blood and bone marrow associated with complete remission of recurrent AML.
- Published in:
- Cancer Cell International, 2004, v. 4, p. S17, doi. 10.1186/1475-2867-4-S1-S17
- By:
- Publication type:
- Article
Peptide vaccination induces specific effector and memory T cells but fails to enhance preexisting T cell immunity.
- Published in:
- Cancer Cell International, 2004, v. 4, p. S48, doi. 10.1186/1475-2867-4-S1-S48
- By:
- Publication type:
- Article
Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Aderhautmelanom Adjuvante Therapie bei Hochrisikopatienten und neue Therapieansätze im metastasierten Stadium.
- Published in:
- Der Ophthalmologe, 2002, v. 99, n. 5, p. 333, doi. 10.1007/s00347-002-0634-9
- By:
- Publication type:
- Article
What can we learn from phase II adjuvant trials in melanoma?
- Published in:
- 2000
- By:
- Publication type:
- Editorial
Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors.
- Published in:
- British Journal of Cancer, 2000, v. 82, n. 1, p. 118, doi. 10.1054/bjoc.1998.0887
- By:
- Publication type:
- Article
Erratum: Immunohistochemical analysis of integrin αvβ3 expression on tumor-associated vessels of human carcinomas. Int. J. Cancer, 71, 320-324 (1997).
- Published in:
- International Journal of Cancer, 1997, v. 72, n. 4, p. 706, doi. 10.1002/(SICI)1097-0215(19970807)72:4<706::AID-IJC25>3.0.CO;2-7
- By:
- Publication type:
- Article
Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Lipopolysaccharide Effectively Up-Regulates B7-1 (CD80) Expression and Costimulatory Function of Human Monocytes.
- Published in:
- Scandinavian Journal of Immunology, 1995, v. 42, n. 6, p. 701, doi. 10.1111/j.1365-3083.1995.tb03714.x
- By:
- Publication type:
- Article
Chemoimmunotherapy of melanoma. Is it time for phase III trials?
- Published in:
- 1995
- By:
- Publication type:
- commentary
Interferon-alpha and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Regional administration of lymphokine-activated killer cells can be superior to intravenous application.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/blood derived stem cell transplantation in patients with malignant lymphohematopoietic disorders.
- Published in:
- 1989
- By:
- Publication type:
- journal article